CYP26A1

Cytochrome P450, family 26, subfamily A, polypeptide 1
Identifiers
Symbols CYP26A1 ; CP26; CYP26; P450RAI; P450RAI1
External IDs OMIM: 602239 MGI: 1096359 HomoloGene: 37349 ChEMBL: 5141 GeneCards: CYP26A1 Gene
EC number 1.14.-.-
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 1592 13082
Ensembl ENSG00000095596 ENSMUSG00000024987
UniProt O43174 O55127
RefSeq (mRNA) NM_000783 NM_007811
RefSeq (protein) NP_000774 NP_031837
Location (UCSC) Chr 10:
93.07 – 93.08 Mb		 Chr 19:
37.7 – 37.7 Mb
PubMed search

Cytochrome P450 26A1 is a protein that in humans is encoded by the CYP26A1 gene.[1][2][3]

Function

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein acts on retinoids, including all-trans-retinoic acid (RA), with both 4-hydroxylation and 18-hydroxylation activities. This enzyme regulates the cellular level of retinoic acid which is involved in regulation of gene expression in both embryonic and adult tissues. Two alternatively spliced transcript variants of this gene, which encode the distinct isoforms, have been reported.[3]

CYP26A1 is over-expressed in colorectal cancer cells compared to normal colonic epithelium but is of no independent prognostic value in patients with colorectal cancer.[4]

References

  1. ↑ White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, Petkovich M (July 1997). "cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450". The Journal of Biological Chemistry 272 (30): 18538–41. doi:10.1074/jbc.272.30.18538. PMID 9228017.
  2. ↑ White JA, Beckett B, Scherer SW, Herbrick JA, Petkovich M (March 1998). "P450RAI (CYP26A1) maps to human chromosome 10q23-q24 and mouse chromosome 19C2-3". Genomics 48 (2): 270–2. doi:10.1006/geno.1997.5157. PMID 9521883.
  3. 1 2 "Entrez Gene: CYP26A1 cytochrome P450, family 26, subfamily A, polypeptide 1".
  4. ↑ Brown GT, Cash BG, Blihoghe D, Johansson P, Alnabulsi A, Murray GI (2014-03-07). "The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer". PloS One 9 (3): e90776. doi:10.1371/journal.pone.0090776. PMID 24608339.

Further reading

  • Duell EA, Kang S, Voorhees JJ (February 1996). "Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid". The Journal of Investigative Dermatology 106 (2): 316–20. doi:10.1111/1523-1747.ep12342972. PMID 8601734. 
  • Ray WJ, Bain G, Yao M, Gottlieb DI (July 1997). "CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family". The Journal of Biological Chemistry 272 (30): 18702–8. doi:10.1074/jbc.272.30.18702. PMID 9228041. 
  • Sonneveld E, van den Brink CE, van der Leede BM, Schulkes RK, Petkovich M, van der Burg B, van der Saag PT (August 1998). "Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells". Cell Growth & Differentiation 9 (8): 629–37. PMID 9716180. 
  • Trofimova-Griffin ME, Juchau MR (November 1998). "Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues". Biochemical and Biophysical Research Communications 252 (2): 487–91. doi:10.1006/bbrc.1998.9659. PMID 9826557. 
  • Popa C, Dicker AJ, Dahler AL, Saunders NA (September 1999). "Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible". The British Journal of Dermatology 141 (3): 460–8. doi:10.1046/j.1365-2133.1999.03039.x. PMID 10583049. 
  • McSorley LC, Daly AK (August 2000). "Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation". Biochemical Pharmacology 60 (4): 517–26. doi:10.1016/S0006-2952(00)00356-7. PMID 10874126. 
  • Loudig O, Babichuk C, White J, Abu-Abed S, Mueller C, Petkovich M (September 2000). "Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism". Molecular Endocrinology 14 (9): 1483–97. doi:10.1210/me.14.9.1483. PMID 10976925. 
  • Deng L, Shipley GL, Loose-Mitchell DS, Stancel GM, Broaddus R, Pickar JH, Davies PJ (May 2003). "Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium". The Journal of Clinical Endocrinology and Metabolism 88 (5): 2157–63. doi:10.1210/jc.2002-021844. PMID 12727970. 
  • Won JY, Nam EC, Yoo SJ, Kwon HJ, Um SJ, Han HS, Kim SH, Byun Y, Kim SY (August 2004). "The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma". Metabolism 53 (8): 1007–12. doi:10.1016/j.metabol.2003.12.015. PMID 15281009. 
  • Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M (November 2005). "Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility". The Biochemical Journal 392 (Pt 1): 241–8. doi:10.1042/BJ20050874. PMC 1317683. PMID 16053444. 
  • Ozpolat B, Mehta K, Lopez-Berestein G (October 2005). "Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells". Leukemia & Lymphoma 46 (10): 1497–506. doi:10.1080/10428190500174737. PMID 16194896. 
  • Heise R, Mey J, Neis MM, Marquardt Y, Joussen S, Ott H, Wiederholt T, Kurschat P, Megahed M, Bickers DR, Merk HF, Baron JM (November 2006). "Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models". The Journal of Investigative Dermatology 126 (11): 2473–80. doi:10.1038/sj.jid.5700432. PMID 16778795. 
  • Rat E, Billaut-Laden I, Allorge D, Lo-Guidice JM, Tellier M, Cauffiez C, Jonckheere N, van Seuningen I, Lhermitte M, Romano A, Guéant JL, Broly F (June 2006). "Evidence for a functional genetic polymorphism of the human retinoic acid-metabolizing enzyme CYP26A1, an enzyme that may be involved in spina bifida". Birth Defects Research. Part A, Clinical and Molecular Teratology 76 (6): 491–8. doi:10.1002/bdra.20275. PMID 16933217. 
  • Gomaa MS, Yee SW, Milbourne CE, Barbera MC, Simons C, Brancale A (August 2006). "Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding". Journal of Enzyme Inhibition and Medicinal Chemistry 21 (4): 361–9. doi:10.1080/14756360600742014. PMID 17059167. 
  • Quere R, Baudet A, Cassinat B, Bertrand G, Marti J, Manchon L, Piquemal D, Chomienne C, Commes T (May 2007). "Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity". Blood 109 (10): 4450–60. doi:10.1182/blood-2006-10-051086. PMID 17218384. 
  • Lee SJ, Perera L, Coulter SJ, Mohrenweiser HW, Jetten A, Goldstein JA (March 2007). "The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system". Pharmacogenetics and Genomics 17 (3): 169–80. doi:10.1097/FPC.0b013e32801152d6. PMC 2393551. PMID 17460545. 


This article is issued from Wikipedia - version of the Thursday, April 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.